Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098488
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2004-12-07
Brief Title:
17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Chronic Lymphocytic Leukemia |
| B-cell Chronic Lymphocytic Leukemia |
| Prolymphocytic Leukemia |
Keywords: